Exisulind, a selective apoptotic antineoplastic drug

By Goluboff Erik T  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 10, 2001-10 ,pp. : 1875-1882

Informa Healthcare

Access to resources Recommend Favorite

Treatment with exisulind resulted in regression of adenomatous colon polyps

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Synthesis and Activity of Fluorinated Derivatives of Sulindac Sulphide and Sulindac Sulphone

By Jung M.   Wahl A.F.   Neupert W.   Geisslinger G.   Senter P.D.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 5, 2000-05 ,pp. : 217-221

Pharmaceutical Press

Access to resources Recommend Favorite

Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis

By Garcia Agustin   Iqbal Syma   Quinn David   Edwards Susan   Lenz Heinz   Weber Jeff  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 79-83

Springer Publishing Company

Access to resources Recommend Favorite

Differential effects of sulindac on renal hemodynamics and function in the rat

By Kramp R.A.   Caron N.   Genard J.   Lejeune C.   Gulbis E.   Herman A.  

European Journal of Pharmacology, Vol. 330, Iss. 2, 1997-07 ,pp. : 165-176

Elsevier

Access to resources Recommend Favorite